Recent insider selling at TechTarget and lack of insider buying over the past year raises caution. Strong but not outstanding insider ownership indicates some alignment between management and smaller shareholders, but the lack of insider buying and recent selling makes us cautious about the company.
Morning Movers Gapping up $スターバックス(SBUX.US)$stock rose 3.7% after the coffee chain cut its annual sales forecast, warning of softer demand in January and a slow recovery in China. However, even more weakness had been expected following disappointing store traffic in November and December. $ノボ・ノルディスク(NVO.US)$stock rose 0.5% after the Danish drugmaker forecast another year of double-digit growth due to the populari...
Analysts voice worry over TechTarget's decreasing ROCE, increasing capital employment amidst shrinking revenues. Despite dim financial metrics, the stock jumped 177%, suggesting a market optimism. Exercise caution with this stock, its poor performance warrants an in-depth risk investigation.
Given TechTarget's high volatility, negative earnings growth, and above-average PE ratio, the stock may currently seem a less attractive investment, especially considering the near-term risk and uncertainty.
Despite TechTarget's impressive financial performance and higher ROE than its competitors, its heavy reliance on debt is a significant risk for potential investors. Hence, despite a good ROE, TechTarget might not be an ideal stock choice.
$テックターゲット(TTGT.US)$7 months cup w/ handle looks perfect Up/Down vol 1.97 (strong demand) Multiple pocket pivots through out the base All resulting in OBV printing 7 new highs before price in that handle
テックターゲットに関するコメント
コラムToday's Morning Movers and Top Ratings: GOOGL, AMD, TSLA, SBUX and More
Gapping up
$スターバックス(SBUX.US)$ stock rose 3.7% after the coffee chain cut its annual sales forecast, warning of softer demand in January and a slow recovery in China. However, even more weakness had been expected following disappointing store traffic in November and December.
$ノボ・ノルディスク(NVO.US)$ stock rose 0.5% after the Danish drugmaker forecast another year of double-digit growth due to the populari...
Up/Down vol 1.97 (strong demand)
Multiple pocket pivots through out the base
All resulting in OBV printing 7 new highs before price in that handle
まだコメントはありません